Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment

doi:10.3748/wjg.v29.i40.5566

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4290)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

1714

Figures (1-5)

357

Tables (1-5)

258

Sum=2462

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

242

Download

634

Sum=876

Publishing Process of This Article

Item

Count

Browse

175

Download

633

Sum=808

Oct 28, 2023 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 28, 2023; 29(40): 5566-5581
Published online Oct 28, 2023. doi: 10.3748/wjg.v29.i40.5566

Full Size Figure Download Figure

Figure 4 Kaplan–Meier analysis of cancer-specific survival according to CD8+ and FoxP3+ T cell counts in small bowel adenocarcinoma evaluated by log-rank tests. A: Survival based on CD8+ T cell counts in overall cases; B: Survival based on FoxP3+ T cell counts in overall cases; C: Survival based on FoxP3+/CD8+ T cell counts in overall cases.

Citation: Hoshimoto A, Tatsuguchi A, Hamakubo R, Nishimoto T, Omori J, Akimoto N, Tanaka S, Fujimori S, Hatori T, Shimizu A, Iwakiri K. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. World J Gastroenterol 2023; 29(40): 5566-5581
URL: https://www.wjgnet.com/1007-9327/full/v29/i40/5566.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i40.5566